Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Pathology|October 21, 2022
LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasiaHemamali Samaratunga, Lars Egevad, Michelle Thunders, et al.European Radiology|November 7, 2013
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinomaJoe H Chang, Daryl Lim Joon, Sze Ting Lee, et al.BJU International|October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cellsLaura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.Cancer Cell|April 2, 2019
Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D ImagingAnne C Rios, Bianca D Capaldo, François Vaillant, et al.Pathology|July 8, 2019
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementationJohn R Srigley, Brett Delahunt, Hemamali Samaratunga, et al.The American Journal of Surgical Pathology|July 7, 2021
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3Jia-Min B Pang, Belinda Castles, David J Byrne, et al.The Prostate|June 19, 2019
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancerLaura H Porter, Mitchell G Lawrence, Hong Wang, et al.Journal for Immunotherapy of Cancer|June 28, 2022
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genesAnna Sofia Trigos, Anupama Pasam, Patricia Banks, et al.The Journal of Pathology|January 19, 2018
Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphologyAmy E McCart Reed, Jamie R Kutasovic, Katia Nones, et al.Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.Pageof 5